# VEG111485: A QTc Study of Pazopanib

> **NCT00861029** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 2 (actual)

## Conditions studied

- Carcinoma, Renal Cell

## Interventions

- **DRUG:** Pazopanib
- **OTHER:** Placebo for pazopanib
- **DRUG:** Moxifloxacin
- **OTHER:** Placebo for moxifloxacin

## Key facts

- **NCT ID:** NCT00861029
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03-19
- **Primary completion:** 2010-02-15
- **Final completion:** 2010-02-15
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2017-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00861029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00861029, "VEG111485: A QTc Study of Pazopanib". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00861029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*